How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
|Articles|October 1, 2006
- Volume 0 0
USE OF ASPIRIN AND IBUPROFEN
Author(s)Anna D. Garrett, PharmD, BCPS, CPP
Advertisement
A recent warning issued by the FDA cautions health care providers regarding a potential interaction between lowdose aspirin and ibuprofen. Ex vivo studies have shown that ibuprofen interferes with the antiplatelet effects of aspirin (81 mg immediate-release). This interaction appears to be most significant when ibuprofen is taken within 30 minutes after taking aspirin. The FDA states in the warning:
- Occasional use of ibuprofen is likely to cause minimal risk
- Spacing of ibuprofen at least 30 minutes after, or more than 8 hours before, aspirin ingestion is suggested
- This problem exists only with immediate-release aspirin.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
Articles in this issue
about 20 years ago
Equation for Success: Diabetes Medication, Diet, and Exerciseabout 20 years ago
Rx Product Newsabout 20 years ago
OTC Product Newsabout 20 years ago
can you READ these Rxs?about 20 years ago
Juvenile Anabolic Steroid Abuseabout 20 years ago
Compounding Hotlineabout 20 years ago
RESPy AWARD: A Role Model for Pharmacy Studentsabout 20 years ago
Ouch! Time for Flu Shotsabout 20 years ago
Supreme Court Declines to Review Generic Marketing PactsAdvertisement
Related to this article
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
Could Cemdisiran Keep Patients With Myasthenia Gravis Out of the Hospital?
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
5